潘金莲被吸乳揉到高潮的视频,久久99久久99精品免观看,在电影院里拨开内裤挺进,护士交换粗吟配乱大交动态图

Home > Offer to Sell > Intermediates > Pharmaceutical_intermediates > Imatinib Mesylate

Imatinib Mesylate

Inquiry
  Post Date: Apr 21,2025
  Expiry Date: Oct 18,2025
  Detailed Description: Cas No. :220127-57-1 Specs:99.0%
Please feel free to contact us for our stock position and price.

Call us immediately to get the latest batch of COA and firm offer.

The packaging method depends on the quantity and product property. We also offer a flexible packaging service as per customer’s requirement.

Under normal circumstances, all quotations include domestic freight.

Hereby we highlight some key messages for your information:

1.Quotation: Our quotation is usually valid for 2 to 4 weeks due to the market fluctuation. If you have any inquiry, please contact our sales managers.

2.Quality: We have established the finished products releasing procedure in order to regulate the analysis, examine and releasing management before product distribution, so as to ensure the products quality.

3.Order:Welcome to call and to place the order! Or you can follow us at the below accounts.~~~



Disclaimer:Products are only available to countries where there is no valid patent protection. Products still covered by patents rights are available exclusively for experimental or registration purpose pursuant to national applicable law, and shall be sold in strict accordance with the laws of the People's Republic of China and the laws of the Buyer's country. All products are not for human use. Buyer is obligated for evaluation of the patent situation in its domestic market and shall be held liable for uses which do not fall within the scope of the experimental or registration use exception and are not permitted by national applicable law.

  CAS Registry Number:

220127-57-1

  Synonyms: ;Glivec;gleevec;imatinib methanesulfonate;imatinib mesilate;4-[(4-methylpiperazin-1-yl)methyl]-n-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate;4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate;Imatinibmesylate;Imatinib mesylate(Alpha form);
  Molecular Formula: C30H35N7O4S
  Molecular Weight: 589.71
  Molecular Structure: 220127-57-1 Imatinib Mesylate

  Company: Nanjing CHICO pharmaceutical Co.,Ltd     [ China ]          
  Contact: Kirsten Jiang
  Tel: +86-13057662806;15150674956;15
  Fax: +86-25-52261140
  Email: chico@chicopharm.com;chloewu@chicopharm.cn,sales@chicopharm.com;
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
主站蜘蛛池模板: 阜宁县| 改则县| 临桂县| 莒南县| 马尔康县| 渝北区| 盐源县| 合江县| 宁陕县| 剑河县| 项城市| 太和县| 邹城市| 五寨县| 百色市| 新平| 宜昌市| 定结县| 蓬莱市| 吴川市| 永吉县| 胶南市| 白玉县| 广西| 新干县| 阳东县| 砚山县| 会同县| 绩溪县| 游戏| 自贡市| 泊头市| 牟定县| 准格尔旗| 贡觉县| 松江区| 潼关县| 辽源市| 麻城市| 宜川县| 房产|